SCHEMBL2201791

SCHEMBL2201791

CCOC(=O)c1c(C)n[nH]c1C1CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.63
KDM4E B2RXH2 5/20 0.41
LMNA P02545 2/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 3/20 0.40
GAA P10253 3/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
POLB P06746 3/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PLAT P00750 1/20 0.39
HTT P42858 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27758273 0.87 PDE4D (0.48) PDE4DLMNASMN1; SMN2RAB9ANPC1
SCHEMBL20471495 0.81 KDM4E (0.50) PDE4DKDM4ELMNAPKMMAPT
SCHEMBL6196509 0.80 PDE4D (0.45) PDE4DKDM4ELMNAMAPTHPGD
SCHEMBL29463552 0.78 HCAR2 (0.50) PDE4DKMT2APLATHCAR2MEN1
SCHEMBL15056281 0.78 KDM4E (0.46) PDE4DKDM4ELMNAMAPTALDH1A1
SCHEMBL353564 0.78 PDE4D (1.00) PDE4DKDM4ELMNAPKMMAPT
SCHEMBL2197680 0.77 PDE4D (0.40) PDE4DKDM4ELMNAMAPTSMN1; SMN2
SCHEMBL2200905 0.77 CDK5 (0.46) KDM4ELMNASMN1; SMN2HPGDALDH1A1
Hydrochloric Acid SCHEMBL15056842 0.77 KDM4E (0.44) PDE4DKDM4ELMNAMAPTALDH1A1
SCHEMBL4442104 0.76 HTT (0.53) PDE4DKDM4EMAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 PDE4D 814/4885KDM4E 3694/4885LMNA 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.